Skip to main content

Dianthus Therapeutics, Inc.

DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001690585

In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.43B in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Dianthus Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
−6 vs. Q1 2023
Shares held
29.0M
−655.3K (−2.2%) vs. Q1 2023
Total value
$22.0M
−$1.56M (−6.6%) vs. Q1 2023
New holders
3
10 more added
Sold out
9
12 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 46 institutions
Q1 2021: 90 institutionsQ2 2021: 97 institutionsQ3 2021: 93 institutionsQ4 2021: 94 institutionsQ1 2022: 93 institutionsQ2 2022: 75 institutionsQ3 2022: 72 institutionsQ4 2022: 54 institutionsQ1 2023: 52 institutionsQ2 2023: 46 institutionsQ3 2023: 30 institutionsQ4 2023: 39 institutionsQ1 2024: 76 institutionsQ2 2024: 74 institutionsQ3 2024: 91 institutionsQ4 2024: 96 institutionsQ1 2025: 99 institutionsQ2 2025: 103 institutionsQ3 2025: 140 institutionsQ4 2025: 166 institutionsQ1 2026: 241 institutionsQ2 2026: 269 institutions
Value heldQ2 2023: $22.0M
Q1 2021: $423.5MQ2 2021: $366.3MQ3 2021: $276.0MQ4 2021: $211.6MQ1 2022: $138.9MQ2 2022: $54.6MQ3 2022: $70.5MQ4 2022: $11.1MQ1 2023: $23.6MQ2 2023: $22.0MQ3 2023: $136.3MQ4 2023: $109.9MQ1 2024: $784.0MQ2 2024: $769.0MQ3 2024: $859.0MQ4 2024: $765.7MQ1 2025: $685.5MQ2 2025: $728.6MQ3 2025: $1.85BQ4 2025: $2.02BQ1 2026: $5.37BQ2 2026: $6.43B
Institutions holding DNTH and their total value by quarter
QuarterHoldersValue
Q2 2026269$6.43B
Q1 2026241$5.37B
Q4 2025166$2.02B
Q3 2025140$1.85B
Q2 2025103$728.6M
Q1 202599$685.5M
Q4 202496$765.7M
Q3 202491$859.0M
Q2 202474$769.0M
Q1 202476$784.0M
Q4 202339$109.9M
Q3 202330$136.3M
Q2 202346$22.0M
Q1 202352$23.6M
Q4 202254$11.1M
Q3 202272$70.5M
Q2 202275$54.6M
Q1 202293$138.9M
Q4 202194$211.6M
Q3 202193$276.0M
Q2 202197$366.3M
Q1 202190$423.5M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding DNTH in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Tang Capital Management LLC6,060,000$4.59M0.68%+10,000+0.2%Added
Nantahala Capital Management, LLC5,000,000$3.79M0.46%+5,000,000New
Atlas Venture Life Science Advisors, LLC3,791,698$2.87M0.36%00.0%Unchanged
Citadel Advisors LLC3,360,001$2.55M0.00%+3,351,181+37,995.2%Added
Alphabet Inc.3,339,138$2.54M0.14%00.0%Unchanged
Vanguard Group Inc1,968,421$1.49M0.00%00.0%Unchanged
Laurion Capital Management LP582,300$441.4K0.02%00.0%Unchanged
Octagon Capital Advisors LP550,000$416.9K0.06%+550,000New
Renaissance Technologies LLC481,700$365.0K0.00%+88,300+22.4%Added
Acadian Asset Management LLC457,690$346.0K0.00%−156,523−25.5%Reduced
Verition Fund Management LLC378,272$286.7K0.00%−1,820,193−82.8%Reduced
BlackRock Inc.364,168$276.0K0.00%−101,801−21.8%Reduced
Geode Capital Management, LLC357,690$271.1K0.00%00.0%Unchanged
Harvard Management Co Inc332,610$252.0K0.02%00.0%Unchanged
RBF Capital, LLC250,822$190.1K0.01%00.0%Unchanged
Bessemer Group Inc237,292$180.0K0.00%00.0%Unchanged
Leonteq Securities AG200,000$151.6K0.02%00.0%Unchanged
Two Sigma Advisers, LP177,400$134.5K0.00%+23,346+15.2%Added
Harbor Capital Advisors, Inc.167,454$126.9K0.03%+15,316+10.1%Added
Credit Suisse AG149,300$113.2K0.00%−44,200−22.8%Reduced
State Street Corp139,207$105.5K0.00%00.0%Unchanged
Two Sigma Investments, LP120,269$91.2K0.00%+28,896+31.6%Added
Susquehanna International Group, LLP103,302$78.3K0.00%−78,201−43.1%Reduced
Corsair Capital Management, L.P.100,000$75.8K0.03%+67,154+204.5%Added
Northern Trust Corp71,463$54.2K0.00%−25,872−26.6%Reduced
Bank of New York Mellon Corp60,404$45.8K0.00%−4,917−7.5%Reduced
Cheyne Capital Management (UK) LLP47,170$35.8K0.13%00.0%Unchanged
Fiduciary Trust Co30,555$23.2K0.00%00.0%Unchanged
Bank of America Corp27,917$21.2K0.00%−305−1.1%Reduced
Charles Schwab Investment Management Inc27,369$20.7K0.00%00.0%Unchanged
XTX Topco Ltd26,932$20.4K0.00%+26,932New
Morgan Stanley16,866$12.8K0.00%−500,173−96.7%Reduced
Tower Research Capital LLC (TRC)12,190$9.24K0.00%−999−7.6%Reduced
UBS Group AG11,177$8.47K0.00%+8,380+299.6%Added
Sound View Wealth Advisors Group, LLC10,500$7.96K0.00%00.0%Unchanged
Rathbone Brothers plc10,000$7.58K0.00%00.0%Unchanged
Royal Bank of Canada5,843$4.00K0.00%+471+8.8%Added
BNP Paribas Arbitrage, SA4,474$3.39K0.00%−406−8.3%Reduced
Wells Fargo & Company779$5910.00%+13+1.7%Added
Umb Bank N A742$5620.00%00.0%Unchanged
JPMorgan Chase & Co703$5330.00%00.0%Unchanged
Allworth Financial LP375$2850.00%00.0%Unchanged
Barclays PLC52$390.00%00.0%Unchanged
Institutional & Family Asset Management, LLC50$380.00%00.0%Unchanged
Pension & Wealth Management Advisors, Inc.10$80.00%00.0%Unchanged
Simplex Trading, LLC16$00.00%−3,225−99.5%Reduced
Lion Point Capital, LP0$00.00%−4,558,466−100.0%Sold out
Western Standard LLC0$00.00%−1,439,374−100.0%Sold out
TCW Group Inc0$00.00%−750,000−100.0%Sold out
Marshall Wace, LLP0$00.00%−157,670−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−152,700−100.0%Sold out
National Asset Management, Inc.0$00.00%−13,800−100.0%Sold out
Virtu Financial LLC0$00.00%−10,724−100.0%Sold out
Belpointe Asset Management LLC0$00.00%−5,500−100.0%Sold out
FMR LLC0$00.00%−254−100.0%Sold out